Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02002533 · ClinicalTrials.gov registry record · NA
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
A NA study of Stage II Breast Cancer and Stage IIIA Breast Cancer, sponsored by Gary Morrow.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 6
- Study locations
NCT02002533: Completed NA study of Stage II Breast Cancer and Stage IIIA Breast Cancer, sponsored by Gary Morrow.
NCT02002533 is a NA study of Stage II Breast Cancer and Stage IIIA Breast Cancer that has completed, run by Gary Morrow. The registered enrollment target is 71 participants, below the 317-participant average among 30 other Stage II Breast Cancer trials with a reported enrollment target (78% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02002533, a NA study of Stage II Breast Cancer and Stage IIIA Breast Cancer, has completed, sponsored by Gary Morrow.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 6
- Study locations
Study Summary
This randomized phase II trial studies how well brief behavioral therapy works in improving sleep disorders in patients with stage I-III breast cancer undergoing chemotherapy. Sleep disorder counseling may reduce fatigue and insomnia as well as improve the well-being and quality of life in patients with breast cancer who are undergoing chemotherapy.
Primary Outcome
Will be evaluated by calculating the specific percentage (with 95% confidence interval) of the total number of participants approached that then consented and enrolled in the study.
Conditions Studied
Interventions
- OTHER Educational Intervention
- BEHAVIORAL Telephone-Based Intervention
- BEHAVIORAL Brief Behavioral Therapy
Study Locations (6)
California
- Stanford University Medical Center - Stanford
Illinois
- Heartland NCORP - Decatur
Kansas
- Wichita NCORP - Wichita
Minnesota
- Metro-Minnesota NCORP - Minneapolis
New York
- University of Rochester - Rochester
North Carolina
- Southeast Clinical Oncology Research Program - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2014-02-03 |
| Est. Completion | 2016-12-16 |
| Phase | NA |
What the finished NCT02002533 record still lists
NCT02002533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 317-participant average among 30 other Stage II Breast Cancer trials with a reported enrollment target (78% lower).
The record links to 7 conditions, with Stage II Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Educational Intervention is the first listed.
NCT02002533 lists 6 locations in 6 states (California, Illinois, Kansas).
Frequently Asked Questions
What is clinical trial NCT02002533 about?
NCT02002533 is a clinical study titled "Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy". This randomized phase II trial studies how well brief behavioral therapy works in improving sleep disorders in patients with stage I-III breast cancer undergoing chemotherapy. Sleep disorder counseling may reduce fatigue and insomnia as well as improve the well-being and quality of life in patients ...
What is the current status of trial NCT02002533?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2014-02-03. Estimated completion is 2016-12-16.
What conditions does trial NCT02002533 study?
This clinical trial studies the following conditions: Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Sleep Disorder.
What interventions are being tested in trial NCT02002533?
The interventions under investigation include: Educational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL), Brief Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02002533?
This trial is sponsored by Gary Morrow, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02002533 being conducted?
This trial has 6 study locations across California, Illinois, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02002533's enrollment target sits among peer trials
71 16th of 30 higher than 15 of 30 other Stage II Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage II Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Improving Exercise Capacity With a Tailored Physical Activity Intervention
RECRUITING · NA
-
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
ACTIVE NOT RECRUITING · NA
-
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
ACTIVE NOT RECRUITING · NA
-
Researching the Effect of Exercise on Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI